martes, 10 de noviembre de 2026
Five AI models tackled 227 pharmacy exam questions. Here's where they struggled
https://www.news-medical.net/news/20261109/Five-AI-models-tackled-227-pharmacy-exam-questions-Heres-where-they-struggled.aspx
Five leading AI models faced the same 227 infectious disease exam questions, testing whether their accuracy could withstand the demands of specialized knowledge, complex clinical problems, and visual interpretation.
In a recent study published in the journal Scientific Reports, researchers at the University of the Pacific School of Pharmacy, Stockton, USA, compared the accuracy of five large language models (LLMs) in answering infectious disease-related pharmacy examination questions across different pharmacy subject areas, cognitive levels, and question formats.
ASA urges CMS to protect Medicare's physician supervision standard for anesthesia care
https://www.news-medical.net/news/20261109/ASA-urges-CMS-to-protect-Medicares-physician-supervision-standard-for-anesthesia-care.aspx
The American Society of Anesthesiologists (ASA) today urged the Centers for Medicare & Medicaid Services (CMS) to preserve Medicare's longstanding physician supervision standard for anesthesia care, warning that weakening or eliminating the standard would remove an important Medicare patient-safety safeguard.
AI’s health advice can be accurate and still make us sicker This problem requires a new AI safety standard: behavioral benchmarking
https://www.statnews.com/2026/11/10/ai-health-advice-accuracy-messaging-risk-behavioral-benchmarking
By Jessica Fishman and John L. Jackson Jr.Nov. 10, 2026
Fishman is a behavioral scientist and faculty director of the Message Effects Lab at the Perelman School of Medicine, University of Pennsylvania. Jackson is an anthropologist and provost at the University of Pennsylvania. He launched the Message Effects Lab while serving as dean of Penn’s Annenberg School for Communication.
Pharma is a ‘mixed bag’ when providing drug access to low- and middle-income countries, analysis finds Access plans now cover 69% of late-stage pipeline candidates compared with 18% in 2018
https://www.statnews.com/pharmalot/2026/11/10/access-to-key-drugs-mixed-in-poor-countries-cancer-diabetes/
By Ed SilvermanNov. 10, 2026
Pharmalot Columnist, Senior Writer
State Democratic wins make Medicaid expansion a possibility for more than a million people Three of the 10 states that haven’t expanded Medicaid could reconsider their holdout status
https://www.statnews.com/2026/11/10/medicaid-expansion-holdout-states-midterm-election-power-shift/
By John WilkersonNov. 10, 2026
John Wilkerson, a Washington correspondent, is the author of D.C. Diagnosis, a twice-weekly newsletter about the politics and policy of health and medicine.
The Drug Enterprise in the Age of AI November 10, 2026
Episode 23, AI Series: AI is speeding up the search for new medicines. Can it make the discoveries themselves?
Few people are better placed to answer than Dr. Elias Zerhouni. He ran the National Institutes of Health, then global R&D at Sanofi. He co-founded ModeX Therapeutics, which uses machine learning to design antibodies that don’t exist in nature, and he is now vice chairman and president of its parent company, OPKO Health.
His test for AI: give it every piece of data available in the early 1950s, and it would not have found the double helix. The spark, he argues, is still human.
Chip and Dr. Zerhouni dig into what AI is actually doing in drug development, how the FDA stacks up against regulators abroad, and what a slowdown in AI — and the erosion of American research — could mean for the next generation of cures.
https://www.kff.org/other-health/the-drug-enterprise-in-the-age-of-ai/
Suscribirse a:
Entradas (Atom)

